Electronic healthcare records (EHR)
Retrospective cohort study to assess the increased risk of myelotoxicity due to the combined use of fluoropyrimidines and thiazides
Spain
EU PAS number:
EUPAS1000000181
First published:
18/12/2024
StudyOngoing
Exploring mediation through major bleeding between direct oral anticoagulants and cardiovascular events (MB mediation in CV RWE)
United States
EU PAS number:
EUPAS1000000168
First published:
22/05/2024
StudyOngoing
Prospective Study to Assess Usage, Adherence, Effectiveness of Cabotegravir LA for Pre-Exposure Prophylaxis in the United States in the OPERA Cohort (219844)
United States
EU PAS number:
EUPAS1000000165
First published:
08/05/2025
StudyOngoing
CAB LA PrEP Cohort: Prospective Cohort Study to Assess Effectiveness and Safety of, and Adherence and Resistance to Cabotegravir for Pre-Exposure Prophylaxis in the United States (217671)
United States
EU PAS number:
EUPAS1000000163
First published:
05/06/2024
StudyOngoing
Depicting real-life treatment journeys for patients affected with an immune-inflammatory condition and treated with methotrexate
France
EU PAS number:
EUPAS1000000159
First published:
17/05/2024
StudyOngoing
WINE Study: Roxadustat Treatment of Anemia of Chronic Kidney Disease (CKD) in Real-world Clinical Practice - Observational Study Utilizing Routinely Collected Secondary Data from WiNe Registry in Germany
Germany
EU PAS number:
EUPAS1000000121
First published:
06/05/2025
StudyFinalised
A Rapid Surveillance and Cohort Post-Marketing Safety Study to Evaluate the Safety of Respiratory Syncytial Virus Vaccine (ABRYSVO™) Exposure During Pregnancy in the United States (C3671027)
United States
EU PAS number:
EUPAS1000000115
First published:
13/06/2025
StudyOngoing
Real-world treatment patterns and outcomes of patients with advanced renal cell carcinoma (aRCC) treated with first-line (1L) axitinib + pembrolizumab therapy
United States
EU PAS number:
EUPAS1000000104
First published:
01/07/2025
StudyFinalised
Vaccine Effectiveness, Burden and Impact Studies (VEBIS) - Vaccine effectiveness and the impact of COVID-19 vaccines through routinely collected exposure and outcome data using health registries
Belgium
Denmark
Luxembourg
Norway
Portugal
Spain
EU PAS number:
EUPAS1000000101
First published:
03/04/2025
StudyOngoing
Cardiovascular outcomes of treat-to-target vs fire-and-forget urate-lowering therapy in patients with gout starting urate-lowering therapy. An emulated multicentre open-label two-parallel arm superiority trial carried out in primary care
Sweden
United Kingdom
EU PAS number:
EUPAS1000000086
First published:
15/04/2024
StudyPlanned